Smartwatch-based monitoring using both photoplethysmography and ECG could improve detection of new-onset atrial fibrillation ...

Medtronic (NYSE:MDT) received a CE mark for its Affera Sphere-360 pulsed field ablation catheter, opening access to European ...

The Apple Watch has plenty of potential for health monitoring even after discovery of a condition, and a new study outlines ...

Previously, patients with advanced atrial fibrillation (AF/AFib) had limited treatment choices. Since February 2024, West ...

The system enters a field that sees PFA catheters largely displacing thermal modalities for catheter ablation of AF.

Background Mechanical compression from the ascending aorta on the left atrial anterior wall (LAAW) can cause low voltage areas (LVAs), which are associated with a higher risk of atrial fibrillation ...

A landmark clinical trial from St Bartholomew’s Hospital reveals that the Apple Watch detects recurring AFib faster and reduces unplanned hospitalizations by half following catheter ablation.

A new trial suggests Apple Watch could make a meaningful difference in what happens after atrial fibrillation ablation, not ...

The global ablation technology market growth is driven by rising cardiovascular and cancer cases, and the increasing adoption ...

Affera momentum continues as Medtronic announces CE Mark in Europe & US IDE first cases for Sphere-360 PFA catheter to treat paroxysmal atrial fibrillation: Galway, Ireland Tuesda ...

TactiFlex Duo builds on Abbott’s electrophysiology portfolio with a catheter than can ablate irregular heart rhythms using ...

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain its electrophysiology market share, one analyst said.